Avandia

In 1999, the Food and Drug Administration approved Avandia, the brand name for an anti-diabetic drug. The FDA’s primary medical reviewer questioned Avandia’s safety before FDA approval. After nearly a decade of use and many studies related to the cardiac risk related to the drug, the debate continues. New studies, the American Diabetes Association and the House Oversight and Government Reform Committee all question Avandia’s safety profile.

In the June 14, 2007, issue of The New England Journal of Medicine, Steven Nissen and colleague Kathy Wolski evaluated 42 studies that compared patients taking Avandia with patients not taking it. The studies included nearly 28,000 patients, 15,560 of whom were taking Avandia. The researchers found the risk of a heart attack increased 43 percent among those taking Avandia.

If you are taking Avandia for Type 2 diabetes and suspect you have a heart problem, consult your cardiologist as soon as possible. To learn more about legal claims relating to Avandia, consult an attorney who practices in the area of drugs and medical devices.